Role of haritaki arka in neonatal jaundice

A Randomized Clinical Trial on the Role of Harithaki Arka in Reducing the Severity of Neonatal Jaundice

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/053537

Enrollment

Registered

2023-06-05

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K77- Liver disorders in diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. All new born babies extracted through LSCS 2. Neonates whose parents are willing to give written consent for the trial

Exclusion criteria

Exclusion criteria: 1. New born baby with birth asphyxia 2. New born baby congenital anomalies, sepsis and other systemic illnesses

Design outcomes

Primary

Measure	Time frame
Reduction in the total serum Bilirubin levelTimepoint: Day 0 Day 3 Day 5 Day 7	—

Secondary

Measure	Time frame
changes in the extent of clinical icterus based on crammers criteriaTimepoint: Day 0 Day 3 Day 5 Day 7	—

Countries

India

Contacts

Public ContactNishant Mahaveer Shastri

Sri Dharmasthala Manjunateshwara College of Ayurved and Hospital, Hassan

drnayanpanaje@gmail.com8197589426

Outcome results